BIOLASE, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Leases (Tables)

Leases (Tables)

9 Months Ended

Sep. 30, 2023

Information related to the Company’s right-of-use assets and related liabilities were as follows (in thousands):


	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2023			2022			2023			2022
Cash paid for operating lease liabilities	$	70		$	84		$	230		$	219
Right-of-use assets obtained in exchange for new operating lease obligations	$	—		$	—		$	483		$	562
Weighted-average remaining lease term	2.0 years			2.9 years			2.0 years			2.9 years
Weighted-average discount rate		12.3	%		12.3	%		12.3	%		12.3	%

Schedule of Maturities of Lease Liabilities

Maturities of lease liabilities as of September 30, 2023 for leases that have commenced are as follows (in thousands):


	September 30,
2024	$	1,047
2025		875
2026		207
2027 and thereafter		—
Total future minimum lease obligations		2,129
Less imputed interest		(257	)
Total lease liabilities	$	1,872

Current operating lease liabilities, included in accrued liabilities	$	877
Non-current lease liabilities		995
Total lease liabilities	$	1,872

Future minimum rental commitments under lease agreements with non-cancelable Operating Leases

Future minimum rental commitments under lease agreements, as of September 30, 2023, with non-cancelable terms greater than one year for each of the years ending December 31 are as follows (in thousands):


	Year Ended
	December 31,
Remainder of 2023	$	263
2024		1,046
2025		817
2026		3
2027 and thereafter		—
Total future minimum lease obligations		2,129
Less imputed interest		(257	)
Total lease liabilities	$	1,872